EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Impact of body mass index on progression-free survival and endocrine immune-related adverse events in advanced NSCLC patients treated with nivolumab: A retrospective cohort study

Sila Oksuz, Sedat Yildirim, Hacer Sahika Yildiz, Hatice Odabas, Neslihan Buyukmurat, Nedim Turan

Northern Clinics of Istanbul · 11.05.2026 · 13 (2) · 202-208

DOI: 10.14744/nci.2026.65391 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Northern Clinics of Istanbul, online erschienen am 11.05.2026. Verfasst von Sila Oksuz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkiye. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Body mass index (BMI)immune-related adverse events (irAEs)nivolumab

Autor:innen und Institutionen

  • Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkiye.
  • Department of Administration, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul,Turkiye.

Zitieren

APA

Oksuz, S., Yildirim, S., Yildiz, H. S., Odabas, H., Buyukmurat, N., & Turan, N. (2026). Impact of body mass index on progression-free survival and endocrine immune-related adverse events in advanced NSCLC patients treated with nivolumab: A retrospective cohort study. Northern Clinics of Istanbul, 13(2), 202-208. https://doi.org/10.14744/nci.2026.65391

Vancouver

Oksuz S, Yildirim S, Yildiz HS, Odabas H, Buyukmurat N, Turan N. Impact of body mass index on progression-free survival and endocrine immune-related adverse events in advanced NSCLC patients treated with nivolumab: A retrospective cohort study. Northern Clinics of Istanbul. 2026;13(2):202-208. doi:10.14744/nci.2026.65391

BibTeX
@article{Oksuz2026,
  author = {Oksuz, Sila and Yildirim, Sedat and Yildiz, Hacer Sahika and Odabas, Hatice and Buyukmurat, Neslihan and Turan, Nedim},
  title = {Impact of body mass index on progression-free survival and endocrine immune-related adverse events in advanced NSCLC patients treated with nivolumab: A retrospective cohort study},
  journal = {Northern Clinics of Istanbul},
  year = {2026},
  volume = {13},
  number = {2},
  pages = {202--208},
  doi = {10.14744/nci.2026.65391}
}
Kostenlos starten →